Floatz logo

Tolvaptan

Water Intoxication

Otsuka Pharmaceutical Development & Commercialization, Inc.Small moleculePhase 3Dormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Water Intoxication cohort.

Asset / SponsorPhaseRating
MANNITOL
Istanbul University
N/AD

Same molecule, other indications

Tolvaptan is also rated in:

HyponatremiaDormant
BBB
Indicative ·
78 / 100
View asset →
AscitesDormant
BBB
Indicative ·
78 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →